Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;15(4):558-65.
doi: 10.1007/s11605-011-1458-1. Epub 2011 Feb 15.

Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection

Affiliations

Prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma patients with recurrence after resection

Po-Kuei Hsu et al. J Gastrointest Surg. 2011 Apr.

Abstract

Objective: The survival of recurrent esophageal cancer is poor. But reports regarding prognostic factors for post-recurrence survival are limited. We analyzed the recurrence pattern and the prognostic factors for post-recurrence survival in esophageal squamous cell carcinoma with recurrence after resection.

Methods: Two hundred sixty-eight patients were included. Tumor recurrence occurred in 115 (42.9%) patients. Recurrence pattern was classified as locoregional, distant, and combined recurrence. The post-recurrence survival was defined as the interval between initial recurrence and either death or the last follow-up.

Results: Mediastinum lymphadenopathy was the most common site for locoregional recurrence, whereas lung, liver, and bone were the most common sites for distant recurrence. The overall 1- and 2-year post-recurrence survival rates were 32.6% and 12.6% with a median survival after recurrence of 6.0 months. The independent prognostic factors included liver recurrence (HR = 2.255, 95%CI = 1.073-4.741, p = 0.032), time to recurrence ≤10 months (HR = 2.657, 95%CI = 1.438-4.911, p = 0.002), and no treatment for recurrences (HR = 2.745, 95%CI = 1.635-4.608, p < 0.001).

Conclusions: We identify liver recurrence, early recurrence, and no treatment for recurrence as risk factors for dismal post-recurrence survival.

PubMed Disclaimer

References

    1. Surgery. 2003 Jan;133(1):24-31 - PubMed
    1. Oncol Rep. 2003 Jan-Feb;10(1):81-7 - PubMed
    1. Cell. 2009 Dec 24;139(7):1315-26 - PubMed
    1. World J Surg. 1997 Mar-Apr;21(3):275-81 - PubMed
    1. Cancer. 2003 Apr 1;97(7):1616-23 - PubMed